2197 — Clover Biopharmaceuticals Share News
0.000.00%
Last trade - 00:00- HK$1.52bn
- HK$1.40bn
- CNY3.51m
Brief: Clover Biopharmaceuticals Launches Covid-19 Booster Vaccine In PRC
China's Clover Biopharmaceuticals jumps as co set to launch COVID vaccine in Q1
Brief: Clover Biopharmaceuticals Expects Commercial Launch For SCB-2019 In China To Begin In Q1 2023
Brief: JPMorgan's Long Position In Ordinary Shares Of Clover Biopharmaceuticals Rises To 5.30% - Filing
China's Clover Biopharmaceuticals falls on discounted share sale
Brief: Clover Biopharmaceuticals To Place 128 Million Placing Shares
CanSino Biologics leads slide in vaccine makers as China eases COVID curbs
Brief: Clover Biopharmaceuticals Says Covid-19 Vaccine (Scb-2019 (Cpg 1018/Alum)) Included For Emergency Use In PRC
Brief: Clover’s Vaccine Candidate Reduced Household Transmission Of Sars-Cov-2
Brief: Temasek's Long Position In Ordinary Shares Of Clover Biopharmaceuticals Falls To 4.99% - Filing
CanSino Biologics' HK shares slump as COVID vaccine won't boost earnings
CanSino Biologics leads rally among HK-listed pharmaceutical stocks
Brief: Clover Biopharmaceuticals Says Covid-19 Vaccine Candidate Receives EU Gmp Certificate
Brief: Clover Biopharmaceuticals Says Universal Covid-19 Booster Vaccine Candidate Demonstrates Superior Neutralization Of Omicorn Ba.5
Brief: Clover Biopharmaceuticals Says Its Covid-19 Vaccine Candidate shows Superior Booster Responses
China's Clover jumps most in 3 months on encouraging COVID vaccine trial data
Brief: Clover Biopharmaceuticals Says Covid-19 Booster Vaccine Candidate Demonstrates Neutralization
China's Clover jumps on positive results of COVID vaccine trial
Brief: Clover Biopharmaceuticals Says Positive Phase 2/3 Results In Adolescents For Clover''s Covid-19 Vaccine